BIOXYTRAN, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bioxytran, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Bioxytran, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $2.75M, a 41.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.75M +$803K +41.3% Dec 31, 2023 10-K/A 2025-01-13
Q4 2022 $1.94M +$544K +38.9% Dec 31, 2022 10-K/A 2025-01-13
Q4 2021 $1.4M +$723K +107% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $677K +$503K +287% Dec 31, 2020 10-K 2022-04-11
Q4 2019 $175K +$127K +267% Dec 31, 2019 10-K 2021-04-09
Q4 2018 $47.6K -$2.27M -97.9% Dec 31, 2018 10-K 2020-03-18
Q4 2017 $2.32M -$1.51M -39.5% Dec 31, 2017 10-K 2018-04-02
Q4 2016 $3.83M -$783K -17% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $4.62M +$735K +18.9% Dec 31, 2015 10-K 2017-03-31
Q4 2014 $3.88M +$471K +13.8% Dec 31, 2014 10-K/A 2016-09-20
Q4 2013 $3.41M Dec 31, 2013 10-K 2015-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.